UVEAL MELANOMA, RECURRENT
Clinical trials for UVEAL MELANOMA, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new UVEAL MELANOMA, RECURRENT trials appear
Sign up with your email to follow new studies for UVEAL MELANOMA, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Tumor-Injected drug shows promise in early cancer trial
Disease control Recruiting nowThis early-stage trial tests a new drug called ONM-501, which is injected directly into tumors, either alone or with the immunotherapy cemiplimab (Libtayo). The study includes 168 adults with advanced solid tumors or lymphomas that have not responded to standard treatments. The m…
Matched conditions: UVEAL MELANOMA, RECURRENT
Phase: PHASE1 • Sponsor: OncoNano Medicine, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New capsule aims to fight rare eye cancer that spreads
Disease control Recruiting nowThis study tests an experimental drug called NBM-BMX in people with metastatic uveal melanoma, a rare eye cancer that has spread to other parts of the body. The goal is to find the best dose, check for side effects, and see if the drug can shrink or slow tumors. Participants take…
Matched conditions: UVEAL MELANOMA, RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Novelwise Pharmaceutical Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC